Search Results for: Anil Potti

Why did Science partially retract the XMRV-chronic fatigue syndrome paper?

If past experience is any indication, billions of pixels will be spilled in the coming days as scientists and advocates debate the latest twist in the story of XMRV, or xenotropic murine leukemia-related virus, and chronic fatigue syndrome (CFS). Today’s news is that Science is partially retracting a 2009 paper by Judy Mikovits and colleagues, including … Continue reading Why did Science partially retract the XMRV-chronic fatigue syndrome paper?

Imperial, where Jatinder Ahluwalia earned his PhD, has re-run experiments, and is now reviewing results

If you’ve been wondering what’s happening in the case of Jatinder Ahluwalia, the University of East London researcher who has been found guilty of faking data as a graduate student at Cambridge and of misconduct at University College London, so have we. We last reported, in February, that Imperial College London, where Ahluwalia earned his … Continue reading Imperial, where Jatinder Ahluwalia earned his PhD, has re-run experiments, and is now reviewing results

Why write a blog about retractions?

Post by Ivan Oransky and Adam Marcus The unfolding drama of Anil Potti — a Duke researcher who posed as a Rhodes Scholar and appears to have invented key statistical analyses in a study of how breast cancer responds to chemotherapy — has sent ripples of angst through the cancer community. Potti’s antics prompted editors … Continue reading Why write a blog about retractions?

Weekend reads: COVID-19 issue pulled; an author announces a retraction; FDA sanctions a company for not publishing results

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Editor declines to correct paper with duplicated image after earlier … Continue reading Weekend reads: COVID-19 issue pulled; an author announces a retraction; FDA sanctions a company for not publishing results

Retraction Watch turns 10: A look back, and a look forward

Ten years. On Aug. 3, 2010, we published our first post on Retraction Watch. Titled, “Why write a blog about retractions?”, the welcome letter to readers outlined our hopes for the new blog. Retractions, we felt then, offered “a window into the scientific process,” as well as a source of good stories for journalists. In … Continue reading Retraction Watch turns 10: A look back, and a look forward

NIH to lift Duke sanctions stemming from misconduct

The U.S. National Institutes of Health (NIH) plans to lift sanctions it placed on Duke University more than 1.5 years ago following concerns about how the school responded to recent cases of misconduct. In a memo today to faculty and staff obtained by Retraction Watch, Lawrence Carin, Duke vice president for research wrote:

Feds ban ex-Duke lab tech from funding after she faked data linked to 60 NIH grants

Erin Potts-Kant, who lost her job as a researcher at Duke University in 2013 for embezzling more than $25,000 from the institution, has received a rare permanent Federal funding ban from the U.S. Office of Research Integrity (ORI) after investigators concluded that she had used fabricated data in nearly 120 figures.  The case has been … Continue reading Feds ban ex-Duke lab tech from funding after she faked data linked to 60 NIH grants

Weekend reads: Views on the “grievance studies” hoax; universities play “pass the harasser;” what next for NEJM?

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured questions about what should happen to a paper published by … Continue reading Weekend reads: Views on the “grievance studies” hoax; universities play “pass the harasser;” what next for NEJM?

Bone researcher with lifetime funding ban earns third retraction

A researcher who received a lifetime funding ban for misconduct from a Canadian agency has logged her third retraction, after a re-analysis of her work unveiled “serious inconsistencies.” In July, the Canadian Institutes of Health Research (CIHR) released a report about Sophie Jamal, following an investigation by her former employer, The Women’s College Hospital in Toronto, Canada. … Continue reading Bone researcher with lifetime funding ban earns third retraction

We’ve temporarily removed a Retraction Watch post. Here’s why. (Hint: A bad law.)

Longtime Retraction Watch readers may recall that in 2013, we were forced to temporarily remove ten posts following a false — and frankly ridiculous — copyright infringement claim. Well, it’s happened again. On Wednesday, our host, Bluehost, forwarded us another false copyright claim — aka a Digital Millennium Copyright Act (DMCA) takedown notice — by someone … Continue reading We’ve temporarily removed a Retraction Watch post. Here’s why. (Hint: A bad law.)